Samuel Z Goldhaber
Overview
Explore the profile of Samuel Z Goldhaber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
495
Citations
17056
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leyva H, Hamade N, Krishnathasan D, Goldhaber S, Welker J, Carroll B, et al.
JACC Adv
. 2025 Mar;
4(4):101641.
PMID: 40080920
No abstract available.
2.
Scimeca G, Krishnathasan D, Rashedi S, Lan Z, Sato A, Hamade N, et al.
J Thromb Thrombolysis
. 2025 Mar;
PMID: 40064840
COVID-19 is associated with an increased risk of venous thromboembolism (VTE) in hospitalized patients. Although prior studies have attempted to identify predictors of VTE, restricted sample size and use of...
3.
Rashedi S, Bejjani A, Hunsaker A, Aghayev A, Khairani C, McGonagle B, et al.
Thromb Res
. 2025 Jan;
247:109271.
PMID: 39862754
Background: Isolated subsegmental pulmonary embolism (issPE) is a commonly encountered diagnosis. Although the International Classification of Diseases (ICD)-10 codes are used for research, their validity for identifying issPE is unknown....
4.
Sista A, Troxel A, Tarpey T, Parpia S, Goldhaber S, Stringer W, et al.
Am Heart J
. 2024 Dec;
281:112-122.
PMID: 39638275
Background: The optimal management of patients with intermediate-risk pulmonary embolism (PE), who have right heart dysfunction (determined by a combination of imaging and cardiac biomarkers) but a normal blood pressure,...
5.
Bikdeli B, Leyva H, Muriel A, Lin Z, Piazza G, Khairani C, et al.
Vasc Med
. 2024 Nov;
30(1):58-66.
PMID: 39588564
Introduction: Sex differences exist in risk factors and comorbidities of older adults (aged ⩾ 65 years) with pulmonary embolism (PE). Clinically relevant sex-based treatment disparities for PE have not been...
6.
Bikdeli B, Khairani C, Bejjani A, Lo Y, Mahajan S, Caraballo C, et al.
J Thromb Haemost
. 2024 Nov;
23(2):556-564.
PMID: 39505153
Background: Many research investigations for pulmonary embolism (PE) rely on the International Classification of Diseases 10th Revision (ICD-10) codes for analyses of electronic databases. The validity of ICD-10 codes in...
7.
Talasaz A, McGonagle B, Hajiqasemi M, Ghelichkhan Z, Sadeghipour P, Rashedi S, et al.
Semin Thromb Hemost
. 2024 Sep;
PMID: 39288907
Interactions between food and oral anticoagulants (OACs), particularly vitamin K antagonists such as warfarin, are widely recognized and may also be clinically relevant for direct OACs. Pharmacokinetic and pharmacodynamic interactions...
8.
Konstantinides S, Sanchez O, Goldhaber S, Meneveau N
Presse Med
. 2024 Sep;
53(3):104248.
PMID: 39244019
Only few years after the first report on diagnosing acute pulmonary embolism (PE) with pulmonary angiography, studies began to investigate the effectiveness and safety of thrombolytic therapy for achieving early...
9.
Streiff M, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, et al.
J Natl Compr Canc Netw
. 2024 Sep;
22(7):483-506.
PMID: 39236759
The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease provide strategies for the prevention, diagnosis, and treatment of venous thromboembolism (VTE) in adult patients with cancer. VTE is a common and...
10.
Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19
Bikdeli B, Krishnathasan D, Khairani C, Bejjani A, Davies J, Porio N, et al.
Thromb Res
. 2024 Apr;
237:209-215.
PMID: 38677791
Introduction: Pregnancy may contribute to an excess risk of thrombotic or cardiovascular events. COVID-19 increases the risk of these events, although the risk is relatively limited among outpatients. We sought...